Current pharmaceutical biotechnology2026,Vol.27Issue(5) :564-577,ⅱ.DOI:10.2174/0113892010331837241011060611

Pisum sativum L. Peel Extract Based Biogenic Silver Nanoparticles as Antibiotic Adjuvants to Reverse Multidrug Resistance in Bacteria

Salma Batool Izzah Shahid Moaiza Iftikhar Burhan Haider Farah Deeba Rahman Shah Zaib Saleem
Current pharmaceutical biotechnology2026,Vol.27Issue(5) :564-577,ⅱ.DOI:10.2174/0113892010331837241011060611

Pisum sativum L. Peel Extract Based Biogenic Silver Nanoparticles as Antibiotic Adjuvants to Reverse Multidrug Resistance in Bacteria

Salma Batool 1Izzah Shahid 2Moaiza Iftikhar 1Burhan Haider 1Farah Deeba 3Rahman Shah Zaib Saleem4
扫码查看

作者信息

  • 1. Department of Basic and Applied Chemistry, Faculty of Science and Technology, University of Central Punjab Lahore, 54782, Pakistan
  • 2. Institute of Multidisciplinary Research in Applied Biology (IMAB), Public University of Navarre (UPNA), Campus Arrosadia, Pamplona, 31006, Spain
  • 3. Department of Biochemistry and Biotechnology, The Women University Multan, Pakistan
  • 4. Department of Chemistry and Chemical Engineering, SBA School of Science and Engineering (SBASSE), Lahore University of Management Sciences (LUMS), Lahore, 54792, Pakistan
  • 折叠

Abstract

Introduction: Rapid spread of antimicrobial drug resistance is alarming and demands a sustainable solution. Green synthesis of silver nanoparticles can pave the way for the development of adjuvants that can help overcome bacterial drug resistance. Methods: In the current study, green synthesis of silver nanoparticles utilizing pea (Pisum sativum) peels and their evaluation against multidrug-resistant (MDR) bacterial pathogens has been - proposed. Pea peels were extracted and analyzed for antioxidant potential by non-enzymatic DPPH assay. The extract was used to prepare silver nanoparticles (gAgNPs) characterized using - UV-VIS spectroscopy, SEM, FTIR, and zeta sizer, and evaluated for antibacterial activity. Results: The SEM showed that the gAgNPs were spherical with a size of 59.24 nm ± 0.3, and the zeta sizer gave a PDI of 0.2. As adjuvants, these gAgNPs in combination with vancomycin showed a superior antibacterial activity against vancomycin-resistant E. faecalis (zone of inhibi-tion=66 mm ± 0.41) and vancomycin-resistant P. aeruginosa (35 mm ± 1.41) as compared to vancomycin. Hemolysis was IC_(50) =998.44 μg/mL, creating a therapeutic window for IC_(50) =5 μg/mL, effective against human pathogens. Conclusion: This study suggests these gAgNPs could be a good lead to work as adjuvants with vancomycin against vancomycin-resistant Gram-positive and Gram-negative clinical bacteria and thus warrants further studies.

Key words

Pisum sativum/silver nanoparticles/green synthesis/MDR/antibiotic resistance/DPPH assay

引用本文复制引用

出版年

2026
Current pharmaceutical biotechnology

Current pharmaceutical biotechnology

ISSN:1389-2010
段落导航相关论文